|
February 10, 2005 Attendees:
Ruben Baghdassarian, M.D.
Jack Baurle, TAP Pharmaceuticals
Theodore Val Benderev, M.D.
Guy Biagiotti, M.D.
Richard A. Cerruti, M.D.
Stuart A. Chalfin, M.D.
David A. Chamberlin, M.D.
Junghwan Choi, M.D.
Tom Christie, TAP Pharmaceuticals
Hillary Cox, Pfizer
Cedric Cravens, Pfizer
Lamia Gabal-Shehab, M.D.
David A. Ginsberg, M.D.
Matthew L. Greenberger, M.D.
Jennifer Gruenenfelder, M.D.
Jeffrey E. Kaufman, M.D.
Fred Khonsari, M.D.
Nahid Khonsari
Shannon Kliner, Odyssey Indevus Pharmaceuticals
Luis I. Kobashi, M.D.
Huey Lin, M.D.
August J. Maggio, M.D.
Shelley Martin, Odyssey Indevus Pharmaceuticals
J. Bernard Miller, M.D.
Mike Moon, Novartis
Shannon Nielsen, Yamanouchi Pharma America
Brian Norouzi, M.D.
Josh Randall, M.D.
Richard R. Reed, M.D.
Joel R. Sheiner, M.D.
Alfred A. Sidhom, M.D.
Karan J. Singh, M.D.
Raymond A. Sleiman, M.D.
Aaron Spitz, M.D.
Wendy Thomas, Pfizer
Bernard Turbow, M.D.
Richard Wineland, II, M.D.
|